These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27841789)

  • 61. Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis.
    Clark ST; Diaz Caballero J; Cheang M; Coburn B; Wang PW; Donaldson SL; Zhang Y; Liu M; Keshavjee S; Yau YC; Waters VJ; Elizabeth Tullis D; Guttman DS; Hwang DM
    Sci Rep; 2015 Jun; 5():10932. PubMed ID: 26047320
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Parkins MD; Elborn JS
    Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.
    Vandeplassche E; Tavernier S; Coenye T; Crabbé A
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of anaerobic bacteria in the cystic fibrosis airway.
    Sherrard LJ; Bell SC; Tunney MM
    Curr Opin Pulm Med; 2016 Nov; 22(6):637-43. PubMed ID: 27455453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.
    Sibley CD; Surette MG
    Can J Microbiol; 2011 Feb; 57(2):69-77. PubMed ID: 21326348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.
    Planet PJ
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S23-S31. PubMed ID: 36069898
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.
    Raghuvanshi R; Vasco K; Vázquez-Baeza Y; Jiang L; Morton JT; Li D; Gonzalez A; DeRight Goldasich L; Humphrey G; Ackermann G; Swafford AD; Conrad D; Knight R; Dorrestein PC; Quinn RA
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32576651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.
    Whelan FJ; Heirali AA; Rossi L; Rabin HR; Parkins MD; Surette MG
    PLoS One; 2017; 12(3):e0172811. PubMed ID: 28253277
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The evolving dynamics of the microbial community in the cystic fibrosis lung.
    McGuigan L; Callaghan M
    Environ Microbiol; 2015 Jan; 17(1):16-28. PubMed ID: 24801013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lower Airway Virology in Health and Disease-From Invaders to Symbionts.
    Jankauskaitė L; Misevičienė V; Vaidelienė L; Kėvalas R
    Medicina (Kaunas); 2018 Oct; 54(5):. PubMed ID: 30344303
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation.
    Thornton CS; Acosta N; Surette MG; Parkins MD
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S13-S22. PubMed ID: 36069903
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
    Madan JC
    Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
    [TBL] [Abstract][Full Text] [Related]  

  • 73. One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway.
    Jean-Pierre F; Vyas A; Hampton TH; Henson MA; O'Toole GA
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of the bacterial microbiome in lung disease.
    Dickson RP; Erb-Downward JR; Huffnagle GB
    Expert Rev Respir Med; 2013 Jun; 7(3):245-57. PubMed ID: 23734647
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Viral strategies predisposing to respiratory bacterial superinfections.
    Rossi GA; Fanous H; Colin AA
    Pediatr Pulmonol; 2020 Apr; 55(4):1061-1073. PubMed ID: 32084305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of the microbiome in exacerbations of chronic lung diseases.
    Dickson RP; Martinez FJ; Huffnagle GB
    Lancet; 2014 Aug; 384(9944):691-702. PubMed ID: 25152271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration.
    Bevivino A; Bacci G; Drevinek P; Nelson MT; Hoffman L; Mengoni A
    Trends Mol Med; 2019 Dec; 25(12):1110-1122. PubMed ID: 31439509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiplex PNA-fish to detect cystic fibrosis polymicrobial communities.
    Biotechnol Bioeng; 2017 Feb; 114(2):244. PubMed ID: 28005284
    [No Abstract]   [Full Text] [Related]  

  • 79. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.
    Magalhães AP; Azevedo NF; Pereira MO; Lopes SP
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1163-1181. PubMed ID: 26637419
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pathogenesis of respiratory infections and host defenses.
    Zeiher BG; Hornick DB
    Curr Opin Pulm Med; 1996 May; 2(3):166-73. PubMed ID: 9363135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.